Literature DB >> 8436734

Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction.

J E Olgin1, M M Scheinman.   

Abstract

OBJECTIVES: The goal of the study was to determine short- and long-term success and complications of radiofrequency atrioventricular (AV) junction catheter ablation and to compare these with those of high energy direct current catheter ablation.
BACKGROUND: Catheter ablation of the AV junction with radiofrequency or direct current energy is an accepted treatment for drug-refractory supraventricular tachycardias. Few data are available on the long-term success and effects of radiofrequency ablation or its comparison with direct current ablation.
METHODS: Fifty-four patients who underwent attempted AV junction ablation with radiofrequency energy were followed up for a mean of 24 +/- 8.4 months. These patients were retrospectively compared with 49 patients who underwent attempted AV junction ablation with direct current energy and were followed up for a mean of 41 +/- 23 months.
RESULTS: The early success rate at the time of discharge for radiofrequency ablation was 81.5%, which was not statistically different from that for direct current ablation (85.7%). Fewer sessions were required to achieve complete AV block in the radiofrequency group (1.05 +/- 0.23) (mean +/- SD) compared with the direct current group (1.21 +/- 0.41) (p = 0.02). Although overall complication rates were similar for both groups (9.3% in the radiofrequency group and 8.2% in the direct current group), there was a trend toward more life-threatening early complications in those patients who received direct-current shocks (6.8%) than in those who underwent radiofrequency ablation alone (2.3%) (p = 0.1). Early sudden death (one patient), early ventricular tachycardia (two patients) and cardiac tamponade (one patient) were seen only in those patients who underwent ablation with direct current energy, whereas pulmonary embolism (one patient) was the only early life-threatening complication in the radiofrequency group. During follow-up, the rate of recurrence of AV conduction was the same (5%) for both the direct current and radiofrequency groups. In the direct current group, one patient died suddenly 2 weeks after the procedure and another had a cardiac arrest due to ventricular tachycardia 6 h after the procedure. In the radiofrequency group, two patients died suddenly at 11 and 7 months, respectively. Two patients, one who had unsuccessful radiofrequency ablation and required direct current ablation, were resuscitated from ventricular tachycardia.
CONCLUSIONS: Radiofrequency energy appears to be as efficacious as and perhaps safer than direct current energy for AV junction ablation.

Entities:  

Mesh:

Year:  1993        PMID: 8436734     DOI: 10.1016/0735-1097(93)90084-e

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

Review 1.  Atrioventricular junction ablation and pacemaker implantation for heart failure associated with atrial fibrillation: potential issues and therapies in the setting of acute heart failure syndrome.

Authors:  Jason C Rubenstein; James A Roth
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

2.  [Not Available].

Authors:  S Schickel; J Hluchy; U Jörger; A Langkau; C Linder; G V Sabin
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2000-01

3.  Electroporation: past and future of catheter ablation.

Authors:  Christopher V DeSimone; Suraj Kapa; Samuel J Asirvatham
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-08

4.  Sudden death and its risk factors after atrioventricular junction ablation and pacemaker implantation in patients with atrial fibrillation.

Authors:  Ru-Xing Wang; Hon-Chi Lee; Jia-Ping Li; David O Hodge; Yong-Mei Cha; Paul A Friedman; Thomas M Munger; Komandoor Srivathsan; Behzad B Pavri; Win-Kuang Shen
Journal:  Clin Cardiol       Date:  2016-10-17       Impact factor: 2.882

5.  Short term escape rhythm characteristics after radiofrequency ablation of the atrioventricular junction.

Authors:  M Pelini; R W Peters; K Khalighi; S R Shorofsky; M R Gold
Journal:  J Interv Card Electrophysiol       Date:  2000-04       Impact factor: 1.900

6.  Catheter ablation for successful management of left posterior fascicular tachycardia: an approach guided by recording of fascicular potentials.

Authors:  D Katritsis; S Heald; A Ahsan; M H Anderson; A J Camm; D E Ward; E Rowland
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

7.  Pulmonary vein antrum isolation, atrioventricular junction ablation, and antiarrhythmic drugs combined with direct current cardioversion: survival rates at 7 years follow-up.

Authors:  Kai Sonne; Dimpi Patel; Prasant Mohanty; Luciana Armaganijan; Lucie Riedlbauchova; Moataz El-Ali; Luigi Di Biase; Preeti Venkatraman; Mazen Shaheen; Marketa Kozeluhova; Robert Schweikert; J David Burkhardt; Robert Canby; Oussama Wazni; Walid Saliba; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2009-11       Impact factor: 1.900

Review 8.  Clinical results with catheter ablation: AV junction, atrial fibrillation and ventricular tachycardia.

Authors:  Jonathan Weinstock; Paul J Wang; Munther K Homoud; Mark S Link; N A Mark Estes
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

9.  The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.

Authors:  G N Kay; K A Ellenbogen; M Giudici; M M Redfield; L S Jenkins; M Mianulli; B Wilkoff
Journal:  J Interv Card Electrophysiol       Date:  1998-06       Impact factor: 1.900

10.  Two-Year Follow-up in Atrial Fibrillation Patients Referred for Catheter Ablation of the Atrioventricular Node.

Authors:  Moisés Rodríguez-Mañero; Claudia Pujol Salvador; Luis Martínez-Sande; Carlo de Asmundis; Gian-Battista Chierchia; Alfonso Macías Gallego; Xulio A Fernández-López; Juan José Gavira-Gómez; Javier García-Seara; Naira Calvo; Pedro Brugada; José Ramón González-Juanatey; Ignacio García-Bolao
Journal:  J Atr Fibrillation       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.